{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:40:07Z","timestamp":1787236807764,"version":"build-2736575974"},"reference-count":0,"publisher":"American Society of Hematology","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Classic Hodgkin lymphoma (cHL) is characterized by a tumor microenvironment (TME) containing inflammatory\/immune cells. Follicular lymphoma, mediastinal grey zone lymphoma and diffuse large B-cell lymphomas, may show a TME containing inflammatory\/immune cells, but the TMEs are quite different. In these B-cell lymphomas and cHL, PD-1\/PD-L1 blockade drugs differ in their effectiveness in patients with refractory\/relapsed disease. Research should still explore innovative assays that could reveal which molecules are influencing the sensitivity or the resistance to therapy in an individual patient.<\/jats:p>","DOI":"10.1182\/blood.2022016590","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T16:14:19Z","timestamp":1678464859000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma"],"prefix":"10.1182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-639X","authenticated-orcid":false,"given":"Antonino","family":"Carbone","sequence":"first","affiliation":[{"name":"Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Gloghini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS, Istituto Nazionale Tumori, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Carlo Stella","sequence":"additional","affiliation":[{"name":"Humanitas University, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,3,10]]},"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2022016590\/2037750\/blood.2022016590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2022016590\/2037750\/blood.2022016590.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T16:14:23Z","timestamp":1678464863000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/doi\/10.1182\/blood.2022016590\/494862\/Tumor-microenvironment-contribution-to-checkpoint"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/blood.2022016590","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"blood.2022016590"}}